Msn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 5.20 Cr
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4,667.27 Cr
- Satisfied Charges ₹ 138.66 Cr
- Revenue Growth 26.33%
- Profit Growth 16.43%
- Ebitda 9.12%
- Net Worth 20.47%
- Total Assets 23.17%
About Msn Laboratories
Msn Laboratories Private Limited (MLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 2003 and has a history of 21 years and five months. Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Msn Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.20 Cr.
The company currently has active open charges totaling ₹4,667.27 Cr. The company has closed loans amounting to ₹138.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Msn Laboratories Private Limited India is Vinod Chawla as COMPANY SECRETARY. Laxmi Manne, Bharat Chintapally, and Satyanarayana Manne serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2003PTC041583
- Company No.
041583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Msn Laboratories Private Limited offer?
Msn Laboratories Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Material Testing Labs & Services, Chemical Testing Services, API Intermediate, Carvedilol Intermediates.
Who are the key members and board of directors at Msn Laboratories?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinod Chawla ![]() | Company Secretary | Current | |
Satyanarayana Manne ![]() | Managing Director | 27-Aug-2003 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Laxmi Manne ![]() | Director | 27-Aug-2003 | Current |
Bharat Chintapally ![]() | Director | 01-Feb-2007 | Current |
Financial Performance of Msn Laboratories.
Msn Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.33% increase. The company also saw a substantial improvement in profitability, with a 16.43% increase in profit. The company's net worth Soared by an impressive increase of 20.47%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Msn Laboratories?
In 2023, Msn Laboratories had a promoter holding of 70.45% and a public holding of 29.55%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹4,667.27 Cr
₹138.66 Cr
Charges Breakdown by Lending Institutions
- Others : 1867.29 Cr
- Canara Bank : 600.00 Cr
- Hdfc Bank Limited : 475.00 Cr
- Axis Bank Limited : 466.70 Cr
- Bank Of India : 373.28 Cr
- Others : 885.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 May 2024 | Others | ₹100.00 Cr | Open |
15 May 2024 | Axis Bank Limited | ₹3.50 M | Open |
10 May 2024 | State Bank Of India | ₹300.00 Cr | Open |
25 Mar 2024 | Others | ₹100.00 Cr | Open |
16 Mar 2024 | Axis Bank Limited | ₹3.02 M | Open |
How Many Employees Work at Msn Laboratories?
Msn Laboratories has a workforce of 8889 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Msn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msn Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.